RELATED STUDY
A pilot randomised placebo-controlled trial of cannabidiol to reduce severe behavioural problems in children and adolescents with intellectual disability
Key Findings: The goal of this pilot study was to assess the feasibility of conducting a randomized controlled trial of cannabidiol in treating children with severe behavioral and intellectual disabilities. Overall the efficacy signal favored active drug.
Type of Study: Double Blind Clinical Trial
Study Sample Size: 8
Study Result: Positive
Research Location(s): Australia
Year of Pub: 2021
Cannabinoids Studied: Cannabidiol (CBD)
Phytocannabinoid Source: Cannabis Flower derived
Chemotype: Chemotype III
Dosage: Cannabidiol (20-1000 mg/kg/day)
Citation: Efron D, et al. A pilot randomised placebo-controlled trial of cannabidiol to reduce severe behavioural problems in children and adolescents with intellectual disability. Br J Clin Pharmacol. 2021; 87:436-446. doi: 10.1111/bcp.14399
Authors: Efron D, Freeman JL, Cranswick N, Payne JM, Mulraney M, Prakash C, Lee KJ, Taylor K, Williams K
